PHVS · Pharvaris NV
United States · RS rating 90 · As of 2026-11-03
| Price | 34.78 USD |
|---|---|
| 1-day change | +3.7% |
| RS rating (overall / 1M / 3M / 12M) | 90 / 88 / 75 / 87 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 46 / 54 / 58 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -16.8% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +10.5% |
| Market cap (USD) | $1.8B |